Cagrilintide is a novel, long acting peptide designed to target multiple receptors involved in appetite regulation and energy balance. Unlike traditional weight loss medications that often target a single pathway, cagrilintide acts as Full article: Pharmacotherapy for Obesity: Recent Updates Gastric emptying effects of short acting versus longer acting Download Scientific Diagram Dual and Triple Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data Current Obesity Reports Springer Nature Link Cagrilintide: What It Is and How It's Being Studied for Weight Loss